Structures by: Srivastava P.
Total: 7
C41H35N4O6Ru,F6P
C41H35N4O6Ru,F6P
Dalton transactions (Cambridge, England : 2003) (2019) 48, 31 11822-11828
a=12.9304(11)Å b=24.117(2)Å c=13.6863(12)Å
α=90° β=101.299(2)° γ=90°
C45H33N4O6Ru,F6P
C45H33N4O6Ru,F6P
Dalton transactions (Cambridge, England : 2003) (2019) 48, 31 11822-11828
a=21.829(6)Å b=11.353(3)Å c=37.793(10)Å
α=90° β=101.698(15)° γ=90°
C16H13NO2S
C16H13NO2S
Journal of the Chemical Society, Perkin Transactions 1 (2000) 22 3719
a=11.2827(10)Å b=13.2262(10)Å c=9.2390(10)Å
α=90.00° β=98.352(10)° γ=90.00°
3-cyano-6-(4-chlorophenyl)-4-[Bis(4-fluorophenyl)piperazino]-2H-pyran-2-one
C29H22ClF2N3O2
Journal of the Chemical Society, Perkin Transactions 1 (2001) 16 1953
a=44.292(4)Å b=7.6620(10)Å c=14.9490(10)Å
α=90.00° β=92.71° γ=90.00°
4-(4-chlorophenyl)-2-(2-pyridyl piperazino)-6-cyclopropyl benzonitrile
C25H23ClN4
Journal of the Chemical Society, Perkin Transactions 1 (2001) 16 1953
a=8.4520(10)Å b=12.3980(10)Å c=21.137(2)Å
α=75.020(10)° β=83.190(10)° γ=81.700(10)°
Dioxypyrido[2,3-d]pyrimidine
C17H13BrN4O2
Acta Crystallographica Section E (2001) 57, 5 o408-o410
a=8.728(3)Å b=12.087(4)Å c=8.672(3)Å
α=108.22(3)° β=113.43(2)° γ=91.24(3)°
Pyrazolo[1,5-a]pyridine
C26H17BrFeN4
Acta Crystallographica Section C (2000) 56, 3 e88-e89
a=7.96080(10)Å b=10.68440(10)Å c=12.8215(3)Å
α=93.5770(10)° β=97.7370(10)° γ=99.0460(10)°